Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce today that they have expanded their market awareness program by joining www.StockProfile.com, a customized web-based platform showcasing emerging growth stocks.
StockProfile.com provides the investing public with a free unique information portal for investors who like to conduct their own research and make their own investment decisions. The platform allows users to review and investigate dynamic publicly traded companies in a user-friendly environment.
Cannabis Science is pleased to team up with StockProfile.com in providing independent minded investors seeking new growth companies for investment. The profile is listed at www.StockProfile.com and can be viewed by searching under the stock symbol CBIS.
Dr. Robert Melamede, PhD., Cannabis Science President and CEO, remarked, "In our continuing effort to increase shareholder value and to increase public awareness of our growing and dynamic company we are pleased to join StockProfile.com. This is another important step CBIS is taking to ensure that its shareholders and investment community have continued access to information about how we are building a patient oriented company, especially our efforts to bring badly needed FDA quality pharmaceutical cannabis to those who need it most, our veterans with PTSD and related problems. Public education is a very important part of our mission, so it is extremely exciting to be chosen by StockProfile.com and added to their impressive roster of growth companies."
Heavy cannabis use linked to increased risk of developing a new anxiety disorder